Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BALCHEM CORPListing on record | Buy | $1.2K | conv 22Cluster | SEC | |
BALCHEM CORPListing on record | Buy | $4.9K | conv 22Cluster | SEC | |
BALCHEM CORPListing on record | Buy | $10.1K | conv 22Cluster | SEC | |
BALCHEM CORPListing on record | Buy | $4.9K | conv 22Cluster | SEC | |
BALCHEM CORPListing on record | Buy | $10.1K | conv 22Cluster | SEC | |
BALCHEM CORPListing on record | Buy | $1.2K | conv 22Cluster | SEC | |
BALCHEM CORPListing on record | Buy | n/a (No price was disclosed in the filing) | conv 45 | SEC | |
BALCHEM CORPListing on record | Buy | $105K | conv 12 | SEC | |
BALCHEM CORPListing on record | Buy | $24K | conv 14 | SEC | |
BALCHEM CORPListing on record | Buy | $9K | conv 6 | SEC | |
BALCHEM CORPListing on record | Buy | $222K | conv 9 | SEC | |
BALCHEM CORPListing on record | Buy | $6K | conv 20First in 12mo | SEC | |
Aleritas Capital Corp.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
BROOKE CAPITAL CORPListing unverified | Other | $443.7K | SEC | ||
BROOKE CAPITAL CORPListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
BROOKE CORPListing unverified | Sell | $4.4K | SEC | ||
BROOKE CORPListing unverified | Sell | $10.6K | SEC | ||
BROOKE CORPListing unverified | Sell | $16K | SEC | ||
BROOKE CORPListing unverified | Sell | $1.8K | SEC |